A detailed history of Jfs Wealth Advisors, LLC transactions in Argenx Se stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 36 shares of ARGX stock, worth $22,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Previous 36 -0.0%
Holding current value
$22,619
Previous $15,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$356.95 - $413.29 $356 - $413
-1 Reduced 2.7%
36 $14,000
Q4 2023

Feb 07, 2024

SELL
$338.91 - $506.01 $338 - $506
-1 Reduced 2.63%
37 $14,000
Q3 2023

Nov 02, 2023

SELL
$369.35 - $548.43 $738 - $1,096
-2 Reduced 5.0%
38 $18,000
Q2 2023

Aug 07, 2023

BUY
$360.14 - $422.58 $1,080 - $1,267
3 Added 8.11%
40 $15,000
Q3 2022

Oct 21, 2022

SELL
$343.2 - $395.75 $343 - $395
-1 Reduced 2.63%
37 $13,000
Q2 2022

Aug 02, 2022

BUY
$269.58 - $378.88 $1,078 - $1,515
4 Added 11.76%
38 $14,000
Q1 2022

May 02, 2022

BUY
$254.45 - $351.06 $8,651 - $11,936
34 New
34 $11,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.